June 18, 2025 · Form 4 insider transaction
Dolsten Mikael bought 30,000 shares of Rocket Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 30 days after the transaction.
Holdings include 14,220 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis held by the Reporting Person which cliff vest on December 31, 2025.; Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.